ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs MXN
16.9175
0.06%
Brent Oil
82.025
-1.01%
Bitcoin
62,211.31
-0.20%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. EXACT Sciences Corporation (EXAS)

  7. EXACT Sciences Corporation (EXAS) Noticias

EXAS

EXACT Sciences (EXAS)

EXACT Sciences Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:EXAS
FechaHoraFuenteTítuloSímboloCompañía
07/05/202407:00Business WireExact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024NASDAQ:EXASEXACT Sciences Corporation
01/05/202405:00Business WireExact Sciences to Participate in May Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
15/04/202405:00Business WireExact Sciences Names Aaron Bloomer as New Chief Financial OfficerNASDAQ:EXASEXACT Sciences Corporation
11/04/202405:00Business WireExact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior NotesNASDAQ:EXASEXACT Sciences Corporation
08/04/202411:05Business WireExact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024NASDAQ:EXASEXACT Sciences Corporation
08/04/202405:00Business WireExact Sciences Schedules First Quarter 2024 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
04/04/202405:05Business WireExact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform TreatmentNASDAQ:EXASEXACT Sciences Corporation
28/03/202405:00Business WireExact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-CancerNASDAQ:EXASEXACT Sciences Corporation
27/03/202407:05Business WireExact Sciences Named 2024 Gallup Exceptional Workplace Award WinnerNASDAQ:EXASEXACT Sciences Corporation
13/03/202416:03Business WireThe New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C StudyNASDAQ:EXASEXACT Sciences Corporation
07/03/202406:59Business WireExact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon CancerNASDAQ:EXASEXACT Sciences Corporation
04/03/202419:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202414:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
26/02/202405:00Business WireExact Sciences to Participate in March Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
21/02/202416:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EXASEXACT Sciences Corporation
21/02/202415:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EXASEXACT Sciences Corporation
21/02/202415:05Business WireExact Sciences Announces Fourth Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
01/02/202405:00Business WireExact Sciences Schedules Fourth Quarter 2023 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
07/01/202415:30PR Newswire (US)Exact Sciences Announces Preliminary Fourth Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
02/01/202405:00PR Newswire (US)Exact Sciences to participate in J.P. Morgan Healthcare ConferenceNASDAQ:EXASEXACT Sciences Corporation
07/12/202307:05PR Newswire (US)Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer ScreeningsNASDAQ:EXASEXACT Sciences Corporation
01/12/202302:00PR Newswire (US)Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer PatientsNASDAQ:EXASEXACT Sciences Corporation
17/11/202306:10PR Newswire (US)Exact Sciences Files Patent Infringement Lawsuit Against GeneoscopyNASDAQ:EXASEXACT Sciences Corporation
01/11/202316:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EXASEXACT Sciences Corporation
01/11/202315:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/11/202315:05PR Newswire (US)Exact Sciences Announces Third-Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
01/11/202305:00PR Newswire (US)Exact Sciences to participate in November investor conferencesNASDAQ:EXASEXACT Sciences Corporation
22/10/202314:00PR Newswire (US)Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer DetectionNASDAQ:EXASEXACT Sciences Corporation
20/10/202317:08PR Newswire (US)Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual CongressNASDAQ:EXASEXACT Sciences Corporation
09/10/202305:00PR Newswire (US)Exact Sciences schedules third quarter 2023 earnings callNASDAQ:EXASEXACT Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:EXAS

Su Consulta Reciente

FX
EURUSD
Euro vs US Dollar
NASDAQ
MSFT
Microsoft
AMEX
XLE
Energy Select Sector SPDR
USI
USTECH100
US Tech 100
CCOM
US500
US 500
USOTC
ADDYY
Adidas (QX)
CCOM
OILBRENT
Brent Oil
AMEX
SPY
SPDR S&P 500
CCOM
SILVER
SILVER
NYSE
CVX
Chevron
COIN
SOLUSD
Solana
NASDAQ
GOOGL
Alphabet
NYSE
MRK
Merck
AMEX
XLV
Health Care Select Sector
NYSE
JPM
JP Morgan Chase
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados